United States · FDA National Drug Code directory
Capecitabine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59651-204_eee71cc5-a7d5-4e51-ab02-2fae12418585
- Product NDC
- 59651-204
- Form
- TABLET
- Composition / generic term
- Capecitabine
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20180417
- Source listing expiry
- 20271231
Source-listed ingredients
- CAPECITABINE — 150 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BLISTER PACK in 1 CARTON (59651-204-10) / 10 TABLET in 1 BLISTER PACK · 59651-204-10
- 60 TABLET in 1 BOTTLE (59651-204-60) · 59651-204-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →